The proposed “Non-Benefit Item Management Act,” introduced by Democratic Party lawmaker Baek Hye-ryun, faces intense opposition from South Korean medical associations, which argue the legislation threatens clinical autonomy, patient privacy, and the stability of primary care.
The bill, currently under review in the National Assembly, mandates stricter reporting and disclosure protocols for non-reimbursable medical services.
Clinical Implications of the Proposed Legislation
- Data Transparency and Privacy: The bill requires clinics to submit non-reimbursable (non-benefit) service records to the Health Insurance Review and Assessment Service (HIRA) alongside standard insurance claims, potentially centralizing sensitive patient health data without explicit usage limitations.
- Administrative Burden: Physicians are required to provide detailed comparisons between benefit and non-benefit services and obtain written consent for all non-reimbursable procedures, a measure critics argue will overwhelm office workflows.
- Financial Risk: Failure to comply with these documentation standards could result in administrative fines of up to 5 million won, which medical groups characterize as disproportionate to the administrative nature of the violation.
Medical Associations Cite Risks to Specialized Care
The Korean Association of Plastic Surgeons, the Korean Association of Internal Medicine, and the Korean Association of Otorhinolaryngologists have issued formal statements opposing the bill. The plastic surgeons’ group described the legislation as “anachronistic over-regulation” that could destroy the environment for medical innovation. They argue that the non-benefit system allows for the rapid adoption of new medical technologies that are not yet covered by the national health insurance pool.
“The bill forces a standardized approach on highly customized aesthetic and functional procedures, effectively dismantling patient-centered care,” the Korean Association of Plastic Surgeons stated on November 10. The group further warned that linking these disclosures to private indemnity insurance providers could turn the public health system into a tool for commercial loss-ratio management, compromising the privacy of patient medical records.
Mandatory Non-Benefit Data Submission Risks Patient Privacy
Internal medicine specialists highlighted the risk of identifying individual patient behavior through the mandatory parallel submission of non-benefit data. The Korean Association of Internal Medicine noted on November 11 that while current systems aggregate data by category, the proposed law would create a searchable, patient-specific database of non-reimbursable treatments. They argue that the bill lacks explicit protections regarding how this data will be used or shared with third-party institutions.
“The government’s plan to pile up data without defining its usage or scope directly infringes upon the patient’s right to self-determination regarding their personal information, said the Korean Association of Internal Medicine.”
Regulatory Overlap and Administrative Strain
The Korean Association of Otorhinolaryngologists criticized the legislation for ignoring the structural causes of rising non-benefit costs, such as the delay in covering new medical technologies and the undervaluation of standard insurance reimbursements. They contend that the bill creates a “balloon effect,” where suppressing non-benefit options without fixing the underlying insurance structure will limit patient access to advanced treatments.
The Association also pointed out that the bill introduces redundant regulatory layers. With existing mandates for non-benefit disclosure already in place, the new requirements for written consent and data submission on every minor procedure—such as influenza vaccinations—could distract clinicians from more critical, high-risk patient interactions. They warned that if the government proceeds with the legislation, they are prepared to pursue legal action, including a constitutional appeal.
| Regulatory Requirement | Potential Impact |
|---|---|
| Mandatory Data Submission | Increased risk of sensitive patient data exposure and HIRA administrative burden. |
| Standardized Clinical Guidelines | Constraint on individualized treatment plans and medical innovation. |
| Private Insurance Linkage | Conversion of public health records into commercial risk-assessment tools. |
Plastic Surgeons Threaten Opposition to Forced Legislation
“If the government and the National Assembly ignore the legitimate concerns of the medical community and force the legislation through, we will face them with strong opposition and massive collective action,” the Korean Association of Plastic Surgeons stated.
